Stonegate Capital Partners Updates Coverage On Aemetis Inc. (Nasdaq: AMTX) 4Q25
Aemetis’ 4Q25 results further support the view that the Company is beginning to transition from a capital-intensive buildout story toward a more monetizable low-carbon fuels platform. Dairy RNG remains the clearest proof point, with 12 operating digesters, approximately 405,000 MMBtu of full-year production, and 4Q output up 61% y/y. More importantly, Biogas contributed $10.3 million […]
Stonegate Capital Partners Updates Coverage on OppFi Inc. (NYSE: OPFI) 4Q25
OppFi exited FY25 with strong momentum, delivering record revenue of $597.1M, adj net income of $139.8M, and adj EPS of $1.59, up 13.5%, 69.1%, and $0.64 y/y, respectively, while GAAP net income rose 74.4% to $146.2M. Results were driven by Model 6, broader use of risk-based pricing, and solid operating discipline, which improved unit economics […]
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holding, Inc. (NASDAQ: NTHI) 3Q25
1Q26 sharpened the setup for NTHI as NEO212 completed Phase 1 dose escalation, set a 610 mg RP2D, and now moves toward FDA alignment on a potentially pivotal Phase 2 and possible accelerated pathway. NEO100 is fully enrolled in Phase 2a, with an interim readout expected around August 2026. P&L was secondary as investors now […]
Stonegate Capital Partners Updates Coverage on Park-Ohio Holdings Corp (NasdaqGS: PKOH) 1Q26
PKOH’s 1Q26 supported the improving FY26 setup, but the bigger readthrough is the shift from a broad industrial recovery story toward portfolio mix, execution quality, and backlog conversion. Demand remains healthy across data center, infrastructure, aerospace & defense, and industrial electrification, while Engineered Products backlog is more diversified and should convert over a 9 to […]
Stonegate Capital Partners Updates Coverage on Viemed Healthcare Inc. (NASDAQ: VMD) 4Q25
In FY25, Viemed grew net revenue 21% y/y to $270.3M, generated $14.9M of net income, and delivered record adj. EBITDA of $61.4M. Growth benefited from continued platform momentum and contributions from Lehan’s, with additional tailwinds from the broader shift to in-home care and accelerating sleep/resupply adoption. The key headwind was short-term friction from the updated […]
Stonegate Updates Coverage on Information Services Group Inc. Common Stock (NasdaqGM: III) 1Q26
III’s 1Q26 strengthened the case that ISG’s AI strategy is becoming increasingly monetizable through governance, recurring revenue, and platform-enabled advisory work. The clearest proof point was the company’s largest-ever contract, a multiyear AI governance engagement with a top global manufacturer, which highlights how enterprise AI adoption is creating incremental demand for spend management, vendor oversight, […]
Stonegate Updates Coverage on Information Services Group Inc. Common Stock (NasdaqGM: III) 4Q25
For FY25, III delivered a solid improvement in underlying performance. Revenue was $244.7M, down 1%, but up 7% excluding the prior-year automation divestiture, with growth led by the Americas and an increasing recovery in Europe; Asia-Pacific remained softer. Adjusted EBITDA increased 28% to $32.2M, with margin expanding to 13.2%, while operating cash flow rose 46% […]
Stonegate Capital Partners Updates Coverage on Park-Ohio Holdings Corp (NasdaqGS: PKOH) 4Q25
For FY25, PKOH reported net sales from continuing operations of $1.6B, down ~3.4% y/y, reflecting mixed demand across North American industrial end markets. Adjusted EPS from continuing operations was $2.70 per diluted share (vs. $3.60 prior year), driven by softer sales, though margins held up as profit-improvement initiatives helped offset the volume pressure. Cash generation […]
Stonegate Capital Partners Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) 4Q25
In FY25, NCSM grew revenue 13% to $183.6M despite a still-challenging activity backdrop, driven by product strength across regions, U.S. momentum in fracturing systems and Repeat Precision, continued traction in the North Sea and Middle East, and a $5.2M contribution from ResMetrics following the July acquisition. The quality of growth was solid with ex-ResMetrics revenue […]
Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO) 4Q25
CVEO reported revenue and adj EBITDA of $161.6M and $21.7M, respectively. This compares to our/consensus estimates of $168.9M/$170.2M and $21.6M/$21.2M, respectively. The year-over-year EBITDA increase reflected continued strength in Australia and the benefit of cost-cutting initiatives in Canada. Operating cash flow in the quarter totaled $19.3M, while capital expenditures were $4.8M, primarily related to maintenance […]